Physician profile

Richard Kovach

Cardiovascular Disease · Browns Mills, NJ

NPI 1144209891

$300,382.38

in general payments reported to CMS, 2019-2025

38 companies · $23K in 2025

The $23K reported for 2025 was more than what 97% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

Payments by year

General and research payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program$30,800.00
Consulting Fee$19,650.00
Food and Beverage$12,483.77
Travel and Lodging$11,546.87
Acquisitions$807.72
Honoraria$600.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Bard Peripheral Vascular, INC. $146,072.36 2021-2023
Shockwave Medical, INC $51,528.01 2021-2025 Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter
Philips North America LLC $24,451.02 2019-2025 (6554) Periph Vasc Undiv, (6577) Visions 014, Igt Devices Undivided
Boston Scientific Corporation $20,319.73 2019-2025 Avvigo Guidance System, Eluvia, Ranger
Abbott Laboratories $13,206.43 2019-2025 Mitraclip, Esprit, Amplatzer Amulet
Siemens Medical Solutions USA, INC. $11,987.74 2020-2025 Artis Icono Floor, Magnetom Free.Max, Naeotom Alpha
Venturemed Group, INC. $7,635.51 2019-2021
Medtronic Vascular, INC. $4,615.57 2019-2020
Edwards Lifesciences Corporation $3,858.27 2019-2025 Pascal, Sapien 3 Ultra Resilia
Abiomed $3,005.96 2019-2025 Impella
Medtronic, INC. $2,941.44 2021-2025 Symplicity G3, Corevalve Evolut R, Onyx Frontier
Cardiovascular Systems INC. $2,346.96 2019-2023 Diamondback Coronary
Ancora Heart, INC. $1,964.47 2023-2025 Accucinch
Endologix LLC $1,881.08 2023-2025 Endocross Device, Torus Stent Graft System, Alto Abdominal Stent Graft System
Penumbra, INC. $860.07 2024-2025 Indigo System, Penumbra System, Ruby Coil
Show all 34 companies
CompanyGeneral paymentsYearsTop products
Saranas, INC. $656.85 2021-2023
Terumo Medical Corporation $450.00 2025 Navicross
Inari Medical, INC. $425.56 2021-2024 Ct Thrombectomy System Kit, Flowtriever Catheter, S
Angiodynamics, INC. $328.08 2021-2025 Alphavac, Auryon Laser System 100-120 Vac
Cardiac Dimensions, INC. $291.33 2022-2025
Janssen Pharmaceuticals, INC $245.57 2019-2022
Biotronik INC. $220.10 2022-2024
W. L. Gore & Associates, INC. $193.05 2019-2023 Gore Cardioform Septal Occluder
Cagent Vascular INC $172.33 2022-2025 Serrantor
Surmodics, INC. $136.36 2024 Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Thrombectomy, Sublime Microcatheter, 018, 200cm, Straight
Teleflex LLC $123.27 2023-2024 Turnpike, Manta, Guideliner
Actelion Pharmaceuticals US, INC. $99.65 2025 Uptravi, Opsumit
Astrazeneca Pharmaceuticals LP $95.98 2024 Wainua
Boehringer Ingelheim Pharmaceuticals, INC. $78.59 2019
Cvrx, INC. $68.45 2022
Nipro Medical Corporation $39.89 2025 Hemodialysis System
Cardinal Health 200 LLC $32.54 2021
Avinger INC. $25.32 2019
Veryan Medical Incorporated $24.84 2020

4 companies reported research payments only; those appear in the research section below.

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

Research and ownership

$900.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.

$5,900.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Richard Kovach

$300,382.38

in general payments reported 2019-2025

Years
2019-2025
Top company
Bard Peripheral Vascular, INC.
Context
The $23K reported for 2025 was more than what 97% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/142998/richard-kovach

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.